PHK
IMUX icon

Point72 Hong Kong’s Immunic IMUX Stock Holding History

Point72 Hong Kong’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6
Closed – – 2150
2022
Q2 		$0 Sell
6
-44
-88% -$2.82K ﹤0.01% 2148
2022
Q1 		$6K Buy
+50
New +$5.79K ﹤0.01% 1658
2021
Q4 		– Sell
-12
Closed -$1K – 2118
2021
Q3 		$1K Buy
+12
New +$1.18K ﹤0.01% 1901
2021
Q1 		– Sell
-246
Closed -$38K – 1992
2020
Q4 		$38K Buy
+246
New +$44.2K ﹤0.01% 1303

Other funds holding IMUX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Point72 Hong Kong's IMUX Position: Q3 2022 in Review

Point72 Hong Kong sold out of Immunic (IMUX) in Q3 2022, closing a stake of 6 shares.

Point72 Hong Kong first reported a position in IMUX in Q4 2020 and held it in 4 quarters. The position peaked at $38K in Q4 2020. 65 funds tracked by Wall St. Rank hold IMUX as of Q3 2022.

  • Point72 Hong Kong reported no remaining Immunic position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 6 Immunic shares in Q3 2022.
  • Point72 Hong Kong first reported a position in Immunic in Q4 2020 and held it in 4 quarters.
  • Point72 Hong Kong's Immunic position peaked at $38K in Q4 2020.
  • 65 funds tracked by Wall St. Rank held Immunic as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.